Therapeutic Apheresis
Apheresis is a process of separating the individual components of blood using a machine. Apheresis is commonly done on donors where the entire blood is filtered to obtain individual components i.e., red blood cells, platelets, plasma based on specific gravity to use for transfusion in different patients. Apheresis can also be used as a therapeutic agent to treat various disorders. Therapeutic apheresis is a treatment which removes abnormal cells in the blood which are correlated with a certain disease states. The basic premise of therapeutic apheresis is that removal of certain pathologic cells will reduce organ or tissue damage and may permit reversal of a pathologic process. In order to prevent volume depletion during therapeutic plasmapheresis, the volume of plasma removed must be replaced by plasma, colloid, or crystalloid. Some complications differ depending on whether the replacement fluid is allogeneic (donor) plasma or albumin.
Related Conference of Therapeutic Apheresis
Therapeutic Apheresis Conference Speakers
Recommended Sessions
- Blood Disorders Diagnosis & Treatment
- Blood Transfusion
- Case reports of Hematology
- CellTherapy
- COVID-19 and Hematology
- Disorders of Vascular Bleeding
- Hematology
- Hematology Oncology
- Immunohematology
- Leukaemia and Lymphoma
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation
- New Drug Development in Hematology
- Patient Blood Management
- Pediatric Hematology
- Stem Cell Research
- Thalassemia
- Therapeutic Apheresis
- Thrombosis and Coagulation
- Transfusion Medicine
- Transfusion Transmissible Infections
Related Journals
Are you interested in
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)
